Status:
COMPLETED
Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai
Lead Sponsor:
National institute of Siddha
Conditions:
Tinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are Studied
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
this study is intended to find out the therapeutic efficacy of the siddha drug Kandhaga Rasayanam in Padarthamarai ( Ring worm infection )
Eligibility Criteria
Inclusion
- patients clinically diagnosed with tinea infection.
- direct microscopy skin scraping test positive.
Exclusion
- pregnant or nursing women.
- use of other topical or oral antifungals, immunosuppressive drugs, anthelmintic drugs either currently or during 2 weeks preceeding initiation of drug trial.
- allergy or hyperensitivity to any component of the drug.
- clinical case of eczema, lichen planus, pityriasis versicolor, drug induced eruptions, urticaria, intertrigo, tinea ungium.
- diabetic patients.
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02238912
Start Date
June 1 2012
Last Update
September 12 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National institute of siddha
Chennai, Tamil Nadu, India, 600047